| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
1 Istituto di Ricovero e Cura a Carattere Scientifico H. "Casa Sollievo della Sofferenza" Laboratory of Gene Therapy and Oncology, San Giovanni Rotondo (FG), Italy;
2 Interdisciplinary Center for Biomedical Research, Laboratory for Molecular Medicine and Biotechnology, Università Campus BioMedico, Rome, Italy; and
3 Otolaryngology Head and Neck Surgery and
4 Wilmer Ophthalmological Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland
To identify minimal common areas of allelic loss on chromosome 3, we have mapped both arms of the chromosome in 21 uveal melanomas that did not show monosomy 3 in our previous allelotype study. DNA was isolated from microdissected paraffin sections and amplified by PCR. In an initial screening, 14 microsatellite markers on chromosomal arm 3p and 13 on chromosomal arm 3q were used. Loss of heterozygosity for at least one marker was found in 9 of 21 tumors (43%) on 3p and 8 of 21 tumors (38%) on 3q. The initial analysis defined two common regions of allelic loss on 3p, a 7.3-Mb region between markers D3S1263 and D3S3510 spanning 3p25.3-24.3 and a larger region between markers D3S1578 and D3S1284. The two common regions of allelic loss were further mapped with an additional 14 microsatellite markers. A 1.4-Mb minimal region of allelic loss was identified between microsatellite markers D3S3610 and D3S1554 on 3p25.1-3p25.2. A total of 10 tumors had allelic loss in this region; 2 of these tumors had corresponding putative homozygous deletions. These homozygous deletions may further narrow the region of interest to 0.1 Mb. This 1.4-Mb minimum region of deletion includes several genes that might be involved in the carcinogenesis of uveal melanoma as well as other important tumor types.
This article has been cited by other articles:
|
|
 |
|
  B. Damato, J. Dopierala, A. Klaasen, M. van Dijk, J. Sibbring, and S. E. Coupland Multiplex Ligation-Dependent Probe Amplification of Uveal Melanoma: Correlation with Metastatic Death Invest. Ophthalmol. Vis. Sci., July 1, 2009; 50(7): 3048 - 3055. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Trolet, P. Hupe, I. Huon, I. Lebigot, C. Decraene, O. Delattre, X. Sastre-Garau, S. Saule, J.-P. Thiery, C. Plancher, et al. Genomic Profiling and Identification of High-Risk Uveal Melanoma by Array CGH Analysis of Primary Tumors and Liver Metastases Invest. Ophthalmol. Vis. Sci., June 1, 2009; 50(6): 2572 - 2580. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Damato and S. E. Coupland Translating Uveal Melanoma Cytogenetics Into Clinical Care Arch Ophthalmol, April 1, 2009; 127(4): 423 - 429. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. W. Mensink, J. Vaarwater, E. Kilic, N. C. Naus, N. Mooy, G. Luyten, H. T. Bruggenwirth, D. Paridaens, and A. de Klein Chromosome 3 Intratumor Heterogeneity in Uveal Melanoma Invest. Ophthalmol. Vis. Sci., February 1, 2009; 50(2): 500 - 504. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Rapaport, E. Barillot, and J.-P. Vert Classification of arrayCGH data using fused SVM Bioinformatics, July 1, 2008; 24(13): i375 - i382. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Merhavi, Y. Cohen, B. C. R. Avraham, S. Frenkel, I. Chowers, J. Pe'er, and N. Goldenberg-Cohen Promoter Methylation Status of Multiple Genes in Uveal Melanoma Invest. Ophthalmol. Vis. Sci., October 1, 2007; 48(10): 4403 - 4406. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Meir, M. Zeschnigk, L. Masshofer, J. Pe'er, and I. Chowers The Spatial Distribution of Monosomy 3 and Network Vasculogenic Mimicry Patterns in Uveal Melanoma Invest. Ophthalmol. Vis. Sci., May 1, 2007; 48(5): 1918 - 1922. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. R. Lohmann, T. Hausler, B. Horsthemke, M. Zeschnigk, P. Parrella, and S. L. Merbs Minimal Region of Deletion on Chromosomal Arm 3p25.1-p25.2 in Uveal Melanoma Cancer Res., November 15, 2005; 65(22): 10634 - 10634. [Full Text] [PDF]
|
|
|
|
 |
|
 G. Jonsson, P.-O. Bendahl, T. Sandberg, A. Kurbasic, J. Staaf, L. Sunde, D. G. Cruger, C. Ingvar, H. Olsson, and A. Borg Mapping of a Novel Ocular and Cutaneous Malignant Melanoma Susceptibility Locus to Chromosome 9q21.32 J Natl Cancer Inst, September 21, 2005; 97(18): 1377 - 1382. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
